Bluebird Bio reported $520.1M in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US USD 1.18B 72.15M
Alnylam Pharmaceuticals ALNY:US USD 3.54B 204.84M
Amgen AMGN:US USD 65.12B 1.42B
Avrobio Inc AVRO:US USD 129.5M 16.75M
Biogen BIIB:US USD 24.85B 227.2M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Bluebird Bio BLUE:US USD 520.1M 53.49M
Gilead Sciences GILD:US USD 63.17B 614M
Immunogen IMGN:US USD 358.8M 63.5M
Intercept Pharmaceuticals ICPT:US USD 559.4M 60.81M
IONIS PHARMACEUT IONS:US USD 2.42B 34.16M
Mirati Therapeutics MRTX:US USD 1.3B 23.29M
Moderna Inc MRNA:US USD 26.06B 13M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Novartis NOVN:VX USD 117.45B 1.01B
Ptc Therapeutics PTCT:US USD 1.58B 227.66M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Sangamo Biosciences SGMO:US USD 593.91M 23.21M
Sarepta Therapeutics SRPT:US USD 3.16B 159.3M
Seattle Genetics SGEN:US USD 3.62B 11.26M
Ultragenyx Pharmaceutical RARE:US USD 1.62B 297.85M
Vertex Pharmaceuticals VRTX:US USD 16.71B 1.12B
YTE INCY:US USD 5.51B 191.18M